Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant simvastatin in colorectal cancer for BMP pathway signaling
NL-OMON31290Active, not recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of simvastatin in colorectal adenocarcinoma and colon cancer (2 arms), sponsored by Leiden University Medical Center. Primary endpoints: BMP pathway protein expression in resection specimens, Apoptosis marker expression and 4 more. Started Nov 2008; status: active, not recruiting.
02
Drugs
simvastatin
03
Conditions
colorectal adenocarcinomacolon cancer
Beyond the preview
Go deeper on NL-OMON31290.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31290.